During the past decade, Wilmington Health conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilmington Health" #1 sponsor was "Allergan" with 2 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Guardant Health, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Affinivax, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilmington Health" #1 collaborator was "Molecular Partners AG" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wilmington Health" are "Migraine" (3 trials), "Crohn's Disease" (2 trials), "Episodic Migraine" (2 trials), "Acute Migraine" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Wilmington Health" in a lesser frequency.

Most popular intervention types in "Wilmington Health" are "Drug" (15 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Atogepant" (2 trials), "Zavegepant" (2 trials), "ASP3772" (1 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wilmington Health" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Wilmington Health". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Wilmington Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wilmington Health, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".